TMCnet News

Research and Markets: Global Glaucoma Therapeutics Market Forecasts & Opportunities, 2018
[July 02, 2014]

Research and Markets: Global Glaucoma Therapeutics Market Forecasts & Opportunities, 2018


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/g5q44b/global_glaucoma) has announced the addition of the "Global Glaucoma Therapeutics Market Forecasts & Opportunities, 2018" report to their offering.

Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. The exact etiology of optic nerve damage due to glaucoma is not fully known, but involves mechanical compression and/or decreased blood flow in the optic nerve.

Based on whether the cause of the disease is unknown or known, glaucoma is divided into two types, open angle and closed angle glaucoma. Five main classes of medical treatment are currently used to lower intraocular pressure: prostaglandins, beta blockers, alpha adrenergic agonists, carbonic anhydrase inhibitors, and fixed dose combinations.

The Global Glaucoma Therapeutics market can be divided into five segments: Prostaglandins, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, and Fixed Dose Combinations.



The report covers the Americas and the EMEA and APAC regions; it also covers the Global Glaucoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors


  • Allergan Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.

Other Prominent Vendors

  • Acadia Pharmaceuticals Inc.
  • AC Immune SA
  • Acorn Biomedical Inc.
  • Advanced Cell Technology Inc.
  • Aerie Pharmaceuticals Inc.
  • Carl Zeiss Meditec Inc.
  • Falcon Pharmaceuticals Ltd.
  • Inotek Pharmaceuticals Corp.
  • Lexicon Pharmaceuticals Inc.
  • Neurotech Pharmaceuticals Inc.
  • NicOx SA
  • Otsuka Holdings Co. Ltd.
  • Phytopharm plc
  • Santen Pharmaceuticals Co. Ltd.
  • Senju Pharmaceutical Co. Ltd.
  • SIFI SpA
  • Valeant Pharmaceuticals International Inc.

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Product Profiles
  5. Market Research Methodology
  6. Introduction
  7. Market Landscape
  8. Pipeline Snapshot
  9. Rate of Incidence and Prevalence
  10. Market Segmentation by Drug Class
  11. Geographical Segmentation
  12. Buying Criteria
  13. Market Growth Drivers
  14. Drivers and their Impact
  15. Market Challenges
  16. Impact of Drivers and Challenges
  17. Market Trends
  18. Trends and their Impact
  19. Vendor Landscape
  20. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/g5q44b/global_glaucoma


[ Back To TMCnet.com's Homepage ]